Castration-Resistant Prostate Cancer
5 competing products in clinical development for Castration-Resistant Prostate Cancer.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 22
Phase 31
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + Placebo | Astellas Pharma | Phase 3 | Completed | 40 |
| Enzalutamide | Astellas Pharma | Phase 2 | Completed | 35 |
| Enzalutamide + Flutamide | Astellas Pharma | Phase 2 | Completed | 35 |
| Crizotinib + Enzalutamide | Astellas Pharma | Phase 1 | Completed | 29 |
| enzalutamide | Astellas Pharma | Pre-clinical | Completed | 26 |